The DOI matches its Crossref record; 330 of the 330 references it cites were found in a registry or an index.
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
Open accessAbstract
Although Michael acceptors display a potent and broad spectrum of bioactivity, they have largely been ignored in drug discovery because of their presumed indiscriminate reactivity. As such, a dearth of information exists relevant to the thiol reactivity of natural products and their analogues possessing this moiety. In the midst of recently approved acrylamide-containing drugs, it is clear that a good understanding of the hetero-Michael addition reaction and the relative reactivities of biological thiols with Michael acceptors under physiological conditions is needed for the design and use of these compounds as biological tools and potential therapeutics. This Perspective provides information that will contribute to this understanding, such as kinetics of thiol addition reactions, bioactivities, as well as steric and electronic factors that influence the electrophilicity and reversibility of Michael acceptors. This Perspective is focused on α,β-unsaturated carbonyls given their preponderance in bioactive natural products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary clinical studies have shown that osimertinib is capable of inhibiting the L858R mutant of EGFR up to 12 nM, and the IC50 of L858R/T790M mutant was 1 nM.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [132]
In the citing paper
“The inhibition rate of osimertinib against EGFRL858R/T790M mutant was approximately 200-fold higher than that of the wild type.132”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pearson, R. G. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00905a001 · Cited by 10,475
Absolute hardness: companion parameter to absolute electronegativity
Parr, R. G., & Pearson, R. G. (1983) · Journal of the American Chemical Society · doi:10.1021/ja00364a005 · Cited by 7,998
Parr, R. G., von Szentpály, L., & Liu, S. (1999) · Journal of the American Chemical Society · doi:10.1021/ja983494x · Cited by 7,564
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 4,196
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Density functional approach to the frontier-electron theory of chemical reactivity
Parr, R. G., & Yang, W. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00326a036 · Cited by 3,672
Hard and soft acids and bases, HSAB, part 1: Fundamental principles
Pearson, R. G. (1968) · Journal of Chemical Education · doi:10.1021/ed045p581 · Cited by 2,566
Cross, D. A. E., Ashton, S. E., Ghiorghiu, S., Eberlein, C., Nebhan, C. A., Spitzler, P. J., Orme, J. P., Finlay, M. R. V., Ward, R. A., Mellor, M. J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0337 · Cited by 2,246
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,681
Research works printed but not linked: 6
- Parsons Z. D., 2013, Methods in Enzymology Vol. 528: Hydrogen Peroxide and Cell Signaling Part C, 528, 130
- 2014, FDA Approves Imbruvica to Treat Chronic Lymphocytic Leukemia
- gNodwell, M. B.; Sieber, S. A.Activity-Based Protein Profiling.Springer-Verlag:Berlin, 2012; Vol.324, p165;
- Atsmon J., 1990, Cancer Res., 50, 1879
- Cavalieri E., 2004, Methods in Enzymology, 382, 293
- Geroni C., 2002, Cancer Res., 62, 2332
Cited by
Sorted by citations
Items 401–500 of 618
Triazole and Pyrazole Hybrids of Electrophilic Natural Products as Promising Anticancer Agents
Fermo, A. D., Bisi, A., Orioli, R., Gobbi, S., & Belluti, F. (2026) · Molecules · doi:10.3390/molecules31020355 · Cited by 3
Ortalli, M., Morselli, S., Gritti, T., Suprani, L. A., Castelli, G., Bruno, F., Oliveri, E., Fabrizio, V., Cannarozzi, A., Perrone, G. C. M., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109713 · Cited by 3
Targeting protein–protein interactions with reversible covalent modalities: Non‐cysteine chemistries
Basu, R., & Fletcher, S. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70377 · Cited by 3
3,28-Diacetoxylup-20(29)-ene-30-oic Acid and Its ω-Bromoalkyl Esters
Ponomaryov, D. V., Grigor’eva, L. R., Nemtarev, A. V., Tsepaeva, O. V., Mironov, V. F., Gnezdilov, O. I., & Antipin, I. S. (2020) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428020040107 · Cited by 3
Zhao, Y., Shakeri, A., Hefny, A. A., & Rao, P. P. N. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03256-6 · Cited by 3
4‐Aza Cyclopentenone Prostaglandin Analogues: Synthesis and NF‐κB Inhibitory Activities
Doherty, W., Conway, L., Leveau, B., Nacca, F. G., Chiappa, L., Riccio, A., Roberts, S. M., Santoro, M. G., & Evans, P. (2024) · ChemMedChem · doi:10.1002/cmdc.202400823 · Cited by 3
Shvetsov, A. B., & Semenov, A. (2024) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162024060347 · Cited by 3
A New Potential Atmospheric Accretion Mechanism: Acid-Catalyzed Hetero-Michael Addition Reactions
Fenselau, R. Z., Alotbi, A. R., Lee, C. B., Cronin, J. S., Hill, D. R., Belitsky, J. M., & Elrod, M. J. (2025) · ACS Earth and Space Chemistry · doi:10.1021/acsearthspacechem.4c00342 · Cited by 3
Wang, H., Cao, J., Li, S., Yang, R., He, Q., Hua, S., Pan, Y., Jiang, Z., Li, X., Yu, R., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120435 · Cited by 3
Zuo, Y., Meng, X., Hu, C., Li, J., & Su, Z. (2019) · Catalysis Today · doi:10.1016/j.cattod.2019.03.056 · Cited by 3
Ling, T., Hadi, V., Bollinger, J. C., & Rivas, F. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103846 · Cited by 3
Synthesis of the 4-aza cyclopentenone analogue of Δ12,14-15-deoxy-PGJ2 and S-cysteine adducts
Conway, L., Riccio, A., Santoro, M. G., & Evans, P. (2020) · Tetrahedron Letters · doi:10.1016/j.tetlet.2020.151969 · Cited by 3
Synthesis of Colibactin Pyrrolidono[3,4-d]pyridones via Regioselective C(sp3)–H Activation
Ilazi, A., Huang, B., Campos, V. D. A., & Gademann, K. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c02385 · Cited by 3
Borova, S., Schlutt, C., Nickel, J., & Luxenhofer, R. (2021) · Macromolecular Chemistry and Physics · doi:10.1002/macp.202100331 · Cited by 3
Reja, S., Sarkar, K., Mukherjee, D., Fayaz, T. K. S., Kumar, P., Das, P., Sanphui, P., & Das, R. K. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.134377 · Cited by 3
Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation
Thomas, A., Serafini, M. T., Grant, E. K., Coombs, E. A. J., Bluck, J. P., Schiedel, M., McDonough, M. A., Reynolds, J. K., Lee, B., Platt, M. A., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00437 · Cited by 3
Ionic-molecular organocatalysis enabling allylic amination reactions
Lokhande, S. K., Vaidya, G. N., Venkatesh, A., Patel, V. D., Joshi, P. K., Chatterjee, D. R., & Kumar, D. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.101868 · Cited by 3
Li, P., Tian, X., Zhang, D., Ou, H., Huang, Q., Jin, W., & Liu, R. (2024) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-024-00758-2 · Cited by 3
Dong, S., Huang, H. Y., Li, J., Li, X., Bunu, S. J., Yang, Y., Zhang, Y., Jia, Q., Xu, Z., Li, Y., et al. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01279-z · Cited by 3
He, J., Illingworth, H., Ullrich, S., Ghosh, P., Ton, J., Jackson, C. J., & Nitsche, C. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130176 · Cited by 3
Shaikh, D. S., Parmar, S., & Kalia, D. (2022) · The Analyst · doi:10.1039/d2an00713d · Cited by 3
Mir, S. A., Wani, R. A., Maqbool, M. S., Singh, D., Bharitkar, Y. P., Malik, F. A., & Yousuf, S. K. (2022) · Steroids · doi:10.1016/j.steroids.2022.109172 · Cited by 3
Back to the Medicinal Chemistry Future
Giustiniano, M., Gruber, C. W., Kent, C. N., & Trippier, P. C. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01788 · Cited by 3
He, D., Xu, H., Cao, P., Li, L., Luo, Y., Mon, E. E., Peng, F., Li, L., Dang, Y., & Shao, Z. (2025) · Angewandte Chemie · doi:10.1002/ange.202506881 · Cited by 2
Pham, L., Chaudhary, P., Han, J., Yadav, K., Ghimire, K., Dahal, S., Nguyen, D. T., Kim, B., Nguyen, Y., Nguyen, M., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108647 · Cited by 2
Li, W., Fan, H., Cheng, G., Yu, J.-L., Tian, F., & Wang, L.-X. (2025) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5c00178 · Cited by 2
Kaneko, N., Himeno, M., Kobayashi, Y., Tanifuji, R., Kubota, H., Mizoguchi, H., Muroi, M., Suzuki, T., Sugiyama, M., Dohmae, N., et al. (2025) · RSC Chemical Biology · doi:10.1039/d5cb00268k · Cited by 2
Khyluk, D., Demchuk, O. M., Kurczab, R., Mirosław, B., & Wujec, M. (2025) · Pharmaceuticals · doi:10.3390/ph19010003 · Cited by 2
Bassil, C. F., Dillon, K. A., Anderson, G. R., Mayro, B., Askin, K. N., Winter, P. S., Harry, S. A., Gruber, S., Hall, T. M., Hoj, J. P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68424-1 · Cited by 2
Shi, C., Zhong, W., Qiang, G., Ying, P., Guo, J., Si, Y., & Mou, J. (2026) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2026.130555 · Cited by 2
Redirecting a Native Ene‐Reductase Toward Desaturation With Reverse Enantioselectivity
Zeng, Q., Berga, C., Calvó‐Tusell, C., Garcia‐Borràs, M., & Liu, Z. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.3155545 · Cited by 2
Site-specific profiling of lysine itaconylation via a thiol-based probe
Fu, X., Tang, Z., & Wang, C. (2026) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2026.130731 · Cited by 2
Metal-Free C−H Aroylation of Alkenes Mediated by Triarylamine Visible-Light Photocatalysis
Lasso, J. D., Castillo‐Pazos, D. J., Kieran, A., Chen, E. C., Stock, K. L., Ruchlin, C., Hackney, H. E., Reffner, R., Hamzehpoor, E., Cosa, G., et al. (2026) · ACS Catalysis · doi:10.1021/acscatal.6c03119 · Cited by 2
Hammer, N., Erickson, J. D., Lauridsen, V. H., Jakobsen, J. B., Hansen, B. K., Jacobsen, K. M., Poulsen, T. B., & Jørgensen, K. A. (2018) · Angewandte Chemie · doi:10.1002/ange.201808221 · Cited by 2
Hwu, J. R., Roy, A., Tsay, S., Huang, W., Lin, C., Hwang, K. C., Hu, Y., Shieh, F., Leyssen, P., & Neyts, J. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147646 · Cited by 2
A thiol chemistry perspective on redox medicine
Forshaw, T. E., Tsang, A. W., & Furdui, C. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90219-9.00006-6 · Cited by 2
Tan, Z. H., Chen, L., Li, L., Li, Y., Luo, Y., Wang, F., Dong, S., & Feng, X. (2023) · Angewandte Chemie · doi:10.1002/ange.202306146 · Cited by 2
Pham, L., Jiang, R., Liu, Z., Nguyen, M., Nguyen, Y., Gong, Y., Bi, Y.-R., Kim, H., Kim, Y. R., & Kim, G. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00437 · Cited by 2
Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283
EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Castenmiller, J. J. M., Henauw, S. D., Hirsch‐Ernst, K. I., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., et al. (2024) · EFSA Journal · doi:10.2903/j.efsa.2024.8645 · Cited by 2
Cinnamaldehyde alleviates hepatic steatosis correlating with its electrophilic capability
Weng, J.-Y., Yang, J., Papy, I. S., Yu, B.-T., Ke, Y.-F., Bai, B.-Y., Muskat, M. N., Wu, Q., & Cheng, X. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104142 · Cited by 2
Knibb, S. M. H., Yeremy, B., Williams, D. E., Andersen, R. J., & Golsteyn, R. M. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.106075 · Cited by 2
A novel 1-benzoazepine-derived Michael acceptor and its hetero-adducts active against MRSA
Caletková, O., Pinčeková, L., Nováčiková, J., Gyepes, R., Olejníková, P., Pôbiš, P., Kanďárová, H., & Berkeš, D. (2024) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob01501k · Cited by 2
Perumal, K., Shanthi, M., Hemamalini, V., Shanmugam, R., Shankar, B., & Ramesh, S. (2024) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4923 · Cited by 2
Bognár, G., Kenari, F., Pintér, Z., Borges, I. D., Camargo, A. J., de Oliveira, H. C. B., Sanches-Neto, F. O., Carvalho-Silva, V. H., Napolitano, H. B., & Perjési, P. (2024) · Molecules · doi:10.3390/molecules29235493 · Cited by 2
Choi, S., & Cha, S. (2019) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.11916 · Cited by 2
Curcumin-cinnamaldehyde hybrids as antiproliferative agents against women’s cancer cells
Anselmo, D. B., Polaquini, C. R., Marques, B. C., Ayusso, G. M., de Assis, L. R., Torrezan, G. S., Rahal, P., Fachin, A. L., Calmon, M. F., Marins, M., et al. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-021-02783-w · Cited by 2
Optimized Asymmetric Synthesis of Umuravumbolide
Pérez‐Palau, M., Balaguer-Garcia, E., Romea, P., & Urpı́, F. (2022) · ACS Omega · doi:10.1021/acsomega.2c02304 · Cited by 2
Nicoletti, G., & White, K. S. (2022) · Antibiotics · doi:10.3390/antibiotics11091188 · Cited by 2
Identifying new compounds active against Giardia duodenalis
Hart, C. J. S. (2020) · Griffith Research Online · doi:10.25904/1912/2113 · Cited by 2
A Perspective on Covalent Inhibitors: Research and Development Trends of Warheads and TargetsPreprint
Chen, H., Bird, R. E., Wang, D.-S., Diaz, L. M. L., Iyer, K. A., Ralhan, K., Gustafson, G. R., Kato-Weinstein, J., & Zhou, Q. A. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-wf79n · Cited by 2
Zhang, L., Tabandeh, M., & Deepak, V. (2026) · Research Square · doi:10.21203/rs.3.rs-8630319/v2 · Cited by 2
Nucleophilie von Glutathion als Bindeglied zur Reaktivität von Michael‐Akzeptoren
Mayer, R. J., & Ofial, A. R. (2019) · Angewandte Chemie · doi:10.1002/ange.201909803 · Cited by 1
Wu, Z., & Dong, G. (2022) · Angewandte Chemie · doi:10.1002/ange.202201239 · Cited by 1
Nickel(II)‐Catalyzed Hydrocarbamoylation of Alkynes with Formamides towards Unsaturated Amides
Li, T., Wang, S., Xia, Z., Zhao, J., Zhang, D., Wu, Y., & Liu, Y. (2024) · Helvetica Chimica Acta · doi:10.1002/hlca.202400020 · Cited by 1
First fragment-based screening identifies new chemotypes inhibiting ERAP1-metalloprotease
Fougiaxis, V., Barcherini, V., Petrović, M. M., Sierocki, P., Warenghem, S., Leroux, F., Karroum, N. B., Petit‐Cancelier, F., Rodeschini, V., Roche, D., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116926 · Cited by 1
Zhu, T., Hu, L., Hu, H., Li, Y., Zhu, J., Wu, G., & Xu, D. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108404 · Cited by 1
Use of new approach methodology for hepatic safety assessment of covalent inhibitor drug candidates
Amberntsson, S., Foster, A. J., Chouhan, B., Wilkinson, S. D., Harlfinger, S., Smith, G., Kettle, J. G., Niedbala, M. J., Kavanagh, S. L., & Williams, D. P. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf054 · Cited by 1
Thermolides D and E: Total Synthesis and Stereochemical Revision
Peng, W., Han, F., Liu, J., Wang, C., Minami, A., Oikawa, H., Guo, Y., & Ye, T. (2025) · Organic Letters · doi:10.1021/acs.orglett.5c01326 · Cited by 1
Abdelhady, E. M., Khalil, M. N. A., Rabeh, M. A., Alshehri, S. A., Sabry, O. M., & Hashem, M. M. (2025) · Pharmaceutical Biology · doi:10.1080/13880209.2025.2534573 · Cited by 1
Cinnamoylphenethyl amides from fissistigma bracteolatum and their anti-inflammatory activities
Xue, J., Jia, Y.-Y., Lei, J.-W., Sun, Y., Chen, H., Zhi, Y., Zhao, Z., Zhu, D., Li, G.-S., & Xue, G. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2542256 · Cited by 1
Knibb, S. M. H., Lockwood, T. C., Yeremy, B., Molina, L., Beck, C. R., Sagoe-Wagner, A., Williams, D. E., Andersen, R. J., & Golsteyn, R. M. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100361 · Cited by 1
Electrophilic aryl migration of N -benzyl propiolamides to functionalized-acrylamides
Reddy, C. R., Vinaya, P. P., Ajaykumar, U., & Nagendraprasad, T. (2025) · Chemical Communications · doi:10.1039/d5cc04709a · Cited by 1
Modern Approaches to Anti-EGFR Therapy
Владимировна, Д. Е., Nadyrova, A. I., Luginskaya, S., Kosnyrev, A. S., Владимировна, У. В., & Ilinskaya, O. N. (2025) · Molecular Biology · doi:10.1134/s0026893325700347 · Cited by 1
Targeting enzymes with covalent warheads: Beyond cysteine
Patel, D., Sharma, A., & Duncan, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00064-9 · Cited by 1
Cheke, R. S., & Kharkar, P. S. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70211 · Cited by 1
Żelaszczyk, D., Gunia‐Krzyżak, A., Popiół, J., & Słoczyńska, K. (2025) · Applied Sciences · doi:10.3390/app152412998 · Cited by 1
Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ
Bubenik, M. P., Mäder, P., Orlicky, S. M., Perryman, A. L., Hamel, M., Godbout, C., Falgueyret, J., Kurinov, I. V., Wong, C., Gingras, A., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00643 · Cited by 1
Singh, A., Chopra, M., Mukherjee, A., Kamble, A., Jain, A., Kumar, H., & Sharma, S. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109553 · Cited by 1
Modification of the dermal matrix by senescence associated lipids and its functional consequence
Jelleschitz, S., Kremslehner, C., Nagelreiter, I., Mildner, M., Salek, M., Bauer, C., Stiegler, A., Fors, A. S., Schirato, M., Freystätter, C., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104069 · Cited by 1
Su, L., Huo, T., Zhao, X., Pang, Z., Wang, T., Liu, Y., Dou, X., & Jiao, N. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03064 · Cited by 1
Chlipała, P., Mazur, M., Kancelista, A., Lazar, Z., & Janeczko, T. (2026) · Molecules · doi:10.3390/molecules31061049 · Cited by 1
Aebisher, D., Wilk, I., & Bartusik‐Aebisher, D. (2026) · Molecules · doi:10.3390/molecules31071206 · Cited by 1
Zhang, L., Tabandeh, M., & Deepak, V. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48040412 · Cited by 1
Targeting FLT3 in Acute Myeloid Leukemia: Structural Insights and Key Challenges
da Silva, M. R., Lima, L. C. V., & Barbosa, M. L. D. C. (2026) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.6c00021 · Cited by 1
Maleimides Revisited: Reactivity, Selectivity, and Emerging Synthetic Strategies
Celante, G., Kittelson, K. S., Santos, R. P., Martins, A. C. F., & Gomes, R. D. S. (2026) · European Journal of Organic Chemistry · doi:10.1002/ejoc.70423 · Cited by 1
Calva, J., & Ramírez, J. (2026) · Plants · doi:10.3390/plants15101447 · Cited by 1
Schwer, M., Aldea, S., Engelhardt, M., Stahlecker, J., Rheinganz, J., Langkamp, A., & Boeckler, F. M. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s598622 · Cited by 1
Recent advancements and clinical translation of cinnamaldehyde derivatives in therapeutics
Shakir, S. U., Khan, S. A., Ullah, M., Khan, A., Khan, N. R., & Khan, I. (2026) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2026.2678494 · Cited by 1
Generalized Analysis of Electrophilic Small Molecules
Neelakantan, U., Hu, M., Bhatia, J., Nguyen, H. N., Yeboah, J. (., Vrettos, E. I., Copoulos, D., Nguyen, K. N. M., Babu, M. M., & Blair, D. J. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.8895173 · Cited by 1
Masuda, I., Baugh, S. D. P., McClay, K., Ford, R. J., Tayag, L., Strobel, E. D., Grant, T., DeSando, S. A., Guo, H., Christian, T., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00164 · Cited by 1
Selective Biocatalytic Michael Addition Reactions
Wohlgemuth, R. (2026) · ChemSusChem · doi:10.1002/cssc.202502620 · Cited by 1
Salvatore, M. M., Masi, M., Suleman, M., Kalath, H., Karousa, M. M. M., Ayoub, M. M., Shaito, A. A., & Andolfi, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27157064 · Cited by 1
Kohyama, A., Shiuchi, A., Zhou, Y., Tanioka, M., Sugimoto, K., Sakurai, H., & Matsuya, Y. (2023) · Organic & Biomolecular Chemistry · doi:10.1039/d3ob00357d · Cited by 1
Paulino, R. P., Alves, R. B., Silva, H., & de Freitas, R. P. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03307-y · Cited by 1
Anderson, J. J., & Harki, D. A. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00963k · Cited by 1
Self-citationSemenova, M. N., Кислый, В. П., Maksimenko, A. S., Koblov, I. A., Kuznetsov, N. A., Alisultanov, K. N., Khrustalev, V. N., Samigullina, A. I., Samet, A. V., & Semenov, V. V. (2025) · Mendeleev Communications · doi:10.71267/mencom.7633 · Cited by 1
Carbene Insertion and Furyl Migration Cascade Toward Benzofurans
Zeng, T., Huang, S., Gong, Y., Li, L., Guo, K., Wu, S., Zhan, H., Xu, S., Zhang, X., & Li, B. (2025) · Angewandte Chemie · doi:10.1002/ange.202512949 · Cited by 1
Investigation of Framework-forming Aggregation of Peptide Helices on Membrane Surfaces
Hesselbarth, N. (2025) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-11093 · Cited by 1
DNA-encoded Libraries with Covalent Warheads
Liu, S., Jin, R., Duan, Z., & Lu, X. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016032-00119 · Cited by 1
Su, B., Chen, H., & Li, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.24.678248 · Cited by 1
Modeling Covalent Protein-Ligand Interactions
Ward, R. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11519-3
Gaur, P. (2020) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10556
Rowlands, R. A. (2020) · Deep Blue (University of Michigan)
Exploration of BAY 11-7082 as a novel antibioticPreprint
Coles, V. E., Darveau, P., Zhang, X., Harvey, H., Henriksbo, B. D., Yang, A., Schertzer, J. D., Magolan, J., & Burrows, L. L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.28.462244
Total Synthesis and Chemoproteomics Connect Curcusone Diterpenes with Oncogenic Protein BRAT1Preprint
Cui, C., Dwyer, B. G., Liu, C., Abegg, D., Cai, Z., Hoch, D. G., Yin, X., Qiu, N., Liu, J., Adibekian, A., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13271702
Martínez, M., Mariani, M. L., García, C. E., Ceñal, J. P., & Penissi, A. B. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116009
Kim, T., Kim, H. S., Bang, Y., Kwon, Y., Kim, J., Choi, H. J., & Suh, Y. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107109
Erastin-like anti-Warburg compounds X1 and X4 are GLS2-selective covalent glutaminase inhibitorsPreprint
Crane, C. S., Miele, M., Iyengar, R., Strathmann, N., Jallow, S., & Ulrich, S. M. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-mtk6s
Curcumin in breast cancer treatment
Mishra, Y., & Mishra, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-29913-1.00009-8
A Photochemical Strategy towards Michael Addition Reactions of Cyclopropenes
Hussain, Y., Prasanna, R., Empel, C., Sharma, D., Kloene, L., Zhu, W., Kaiser, A., Weizel, L., Proschak, E., Koenigs, R. M., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202416956
Metadata
- Authors
- Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M.
- Affiliations
- University of Pittsburgh (US)
- University of Minnesota (US)
- Corresponding author
- Harki, Daniel A.
- Brummond, Kay M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-12-20
- Volume
- 60
- Issue
- 3
- Pages
- 839-885
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC5308545
- OpenAlex
- W2564708666
- Cited by
- 588
- References
- 329
- Citations by year
- 2026: 88 · 2025: 71 · 2024: 80 · 2023: 51 · 2022: 58 · 2021: 74 · 2020: 72 · 2019: 51 · 2018: 27 · 2017: 15
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01-GM054161, R01-GM110129)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Physical Organic Chemistry and Reaction Kinetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Reactivity of Sulfur-Containing Compounds
- Keywords
- α,β-unsaturated carbonyl compounds, Michael acceptors, hetero-Michael addition, thiol reactivity, acrylamide, electrophilicity, reaction kinetics, steric and electronic effects, natural products, drug design, biological activity
- MeSH terms
- Humans, Ketones, Sulfhydryl Compounds, Drug Design, Cell Line, Tumor, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review